SCHEMBL7786930

SCHEMBL7786930

CN1C(=O)CNc2ccc(F)cc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 1/20 0.60
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SRD5A1 P18405 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
AKR1B1 P15121 4/20 0.35
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
BRD4 O60885 1/20 0.34
HTR7 P34969 2/20 0.34
HTR1A P08908 2/20 0.33
DRD2 P14416 2/20 0.33
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13089147 0.81 BRPF1 (0.62) BRPF1ALDH1A1SMN1; SMN2SRD5A1AKR1B1
SCHEMBL20571810 0.80 BRPF1 (0.60) BRPF1ALDH1A1SMN1; SMN2SRD5A1GABRA1
SCHEMBL22050042 0.80 BRPF1 (0.60) BRPF1ALDH1A1SMN1; SMN2SRD5A1GABRA1
SCHEMBL30668102 0.80 BRPF1 (0.60) BRPF1ALDH1A1SMN1; SMN2SRD5A1GABRA1
SCHEMBL4818630 0.78 GABRA1 (0.45) BRPF1SRD5A1GABRA1GABRG2GABRB3
SCHEMBL20172716 0.76 BRPF1 (0.55) BRPF1ALDH1A1SMN1; SMN2BRD4CYP1A2
SCHEMBL787636 0.75 BRPF1 (0.39) BRPF1ALDH1A1SRD5A1GABRA1GABRG2
SCHEMBL4476006 0.75 BRPF1 (1.00) BRPF1ALDH1A1SMN1; SMN2GABRA1GABRG2
SCHEMBL30537994 0.75 BRPF1 (1.00) BRPF1ALDH1A1SMN1; SMN2GABRA1GABRG2
SCHEMBL30480866 0.74 BRPF1 (0.49) BRPF1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed